期刊文献+

汉防己甲素注射乳剂的制备及评价 被引量:7

Preparation and Evaluation of Intravenous Tetrandrine Emulsion
原文传递
导出
摘要 目的制备汉防己甲素注射乳剂,并对其进行评价。方法通过正交设计优选汉防己甲素乳剂的最佳处方,并对制备工艺进行优化。对样品进行质量、稳定性研究,并考察了汉防己甲素注射乳剂在大鼠体内的药动学和组织分布及对家兔耳缘静脉的刺激性。结果汉防己甲素注射乳的最佳处方及工艺为:中链甘油三酸酯-大豆油(100 mg.mL-1∶50 mg.mL-1),磷脂30 mg.mL-1,油酸5 mg.mL-1,pH值7~7.5,用105 kPa高压均质2~4次,121℃热压灭菌15 min。本品在低温条件保存较为稳定。与注射液相比,汉防己甲素注射乳显著减小了药物刺激性,两者在大鼠体内药动学参数未出现显著性差异。结论本研究制备获得的汉防己甲素注射乳工艺稳定,质量可控,并能减小汉防己甲素的刺激性。 OBJECTIVE To prepare a new intravenous tetrandrine emulsion and evaluate its properties. METHODS First, the formulation and preparation method of intravenous tetrandrine emulsion were optimized by orthogonal-design. Then the quality and sta- bility were investigated. Furthermore, the pharmacokinetics and tissue distribution as well as the irritation to auricular veins were stud- ied in rabbits. RESULTS The optimized formulation of intravenous tetrandrine emulsion was composed of 100 mg ~ mLi MCT, 50 mg mL LCT,30 mg mL-1 phospholipid, 5 mg mL i oleic acid and water phase. The pH value was adjusted to 7 -7.5. The e- mulsion was homogenized 2 -4 times at 105 kPa, then sterilized for 15 min at 121 C. This intravenous emulsion was stable at low tem- peratures. The pharmacokinetics and tissue distribution of intravenous tetrandrine emulsion were similar with those of tetrandrine injec- tion. However, the emulsion had slighter irritation. CONCLUSION The formulation and preparation method of intravenous tetran- drine emulsion optimized in the current study are reliable. The emulsion can decrease the irritation of tetrandrine.
出处 《中国药学杂志》 CAS CSCD 北大核心 2011年第22期1734-1739,共6页 Chinese Pharmaceutical Journal
关键词 汉防己甲素 注射乳 高压均质 tetrandrine intravenous emulsion high pressure homogenizer
  • 相关文献

参考文献2

二级参考文献27

  • 1Peter DH,Clissold SP.Clarithromycin:a review of its antimicrobial activity,pharmaceutical properties and therapeutic potential[J].Drugs,1992,44:117-164.
  • 2Langtry HD,Brogden RN.Clarithronycin:a review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients[J].Drugs,1997,53:973 -1004.
  • 3Anderson R,Joone G,Rensburg EJ.An in vitro evaluation of the cellular uptake and intraphagocytic bioactivity of clarithromycin,a new macrolide antimicrobial agent[J].J Antimicrob Chemother,1988,22:923-933.
  • 4Celis G,Gea E,Roig J.Comparative tolerability of intravenous erythromycin and clarithromycin in hospitalised patients with community-acquired pneumonia results of a double-blind,randomised,prospective study[J].Clin Drug Invest,2002,22:393-398.
  • 5Torsten Z,Heinrich L,Klaus DR,et al.Comparative tolerability of intravenous azithromycin,clarithromycin and erythromycin in healthy volunteers results of a doubleblind,double-dummy,four-way crossover study[J].Clin Drug Invest,2001,21:527 -536.
  • 6Lovell MW,Johnson HW,Hui HW.Less-painful emulsion formulations for intravenous administration of clarithromycin[J].Int J Pharm,1994,109:45-57.
  • 7Caillot D,Casasnovas O,Solary E,et al.Efficacy and tolerance of an amphotericin B lipid (intralipid) emulsion in the treatment of candidaemia in neutropenic patients[J].J Antimicrob Chemother,1993,31:161-169.
  • 8Menashe YL,Lev L,Shoshanna GS,et al.Side-effect evaluation of a new diazepam formulation:venous sequela reduction following intravenous (iv) injection of a diazepam emulsion in rabbits[J].Pharm Res,1989,6:510 -516.
  • 9Eugene HC,Catherijen AK,Victorine SK,et al.Influence of different fat emulsion based intravenous formulation on the pharmacokinetics and pharmacodynamics of propfol[J].Pharm Res,1998,15:442 -448.
  • 10Toichi T,Kiyoshi K,Yoshinobu T,et al.Long circulating emulsion carrier systems for highly lipophilic drugs[J].Biol Pharm Bull,1994,17:121 -125.

共引文献9

同被引文献111

引证文献7

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部